You are here
News & Events
Vertex Appoints Tom Graney as Senior Vice President and Chief Financial Officer
"As Vertex continues its evolution to a leading global biotech, it is
critical that we continue to build a strong and experienced leadership
"I am thrilled to take on this important role with Vertex, a company
that I have long admired for its unwavering commitment to patients and
to discovering, developing and commercializing transformative medicines
for people with serious and life-threatening diseases," said
Tom Graney Biography
At Ironwood Pharmaceuticals,
Vertex is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious and life-threatening diseases. In addition to clinical development programs in CF, Vertex has more than a dozen ongoing research programs focused on the underlying mechanisms of other serious diseases.
Founded in 1989 in Cambridge, Mass., Vertex's headquarters is now located in Boston's Innovation District. Today, the company has research and development sites and commercial offices in the United States, Europe, Canada and Australia. Vertex is consistently recognized as one of the industry's top places to work, including being named to Science magazine's Top Employers in the life sciences ranking for seven years in a row.
For additional information and the latest updates from the company, please visit www.vrtx.com.
News Provided by Acquire Media